Proliférations épithéliales regorafenib (Stivarga®) cetuximab (Erbitux®)panitumumab (Vectibix®) dabrafenib (Tafinlar®)encorafenib (Braftovi®) vemurafenib (Zelboraf®) cobimetinib (Cotellic®)trametinib (Mekinist®) vismodegib (Erivedge®)